Drugs / FLU HD vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05559476 | Oct 2022 → Mar 2023 | respiratory syncytial virus infectious disease | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FLU HD vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05559476 ↗ |
| Modality | Vaccine | “FLU HD vaccine” NCT05559476 ↗ |
| Route | Intramuscular | “administered intramuscularly” NCT05559476 ↗ |